Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, providing promising improvements across various health-related and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA presents a safer, far more responsible option for therapeu